A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY INVESTIGATING THE EFFICACY AND SAFETY OF BUROSUMAB, AN ANTI-FGF23 ANTIBODY, IN ADULT X-LINKED HYPOPHOSPHATEMIA (XLH)Peter Kamenicky,Robin H. Lachmann,Thomas O. Carpenter,Michel Cohen-Solal,Richard Eastell,M. L. Brandi,R K Crowley,Stuart H. Ralston,M K Javaid,Richard Keen,Karine Briot,Hae Il Cheong,Yasuo Imanishi,Nobuaki Ito,Hiroyuki Tanaka, Leiming Zhang,Christina Theodore-Oklota,Matt Mealiffe,J. San Martin,Karl L. InsognaOSTEOPOROSIS INTERNATIONAL(2018)引用 1|浏览44暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要